138 related articles for article (PubMed ID: 36897548)
1. Prognostic and functional roles of EIF4G1 in lung squamous cell carcinoma.
Bai B; Dong L; Feng M; Zhang Z; Lu Y; Xu Z; Liu Y
Hum Cell; 2023 May; 36(3):1099-1107. PubMed ID: 36897548
[TBL] [Abstract][Full Text] [Related]
2. Elevation of EIF4G1 promotes non-small cell lung cancer progression by activating mTOR signalling.
Lu Y; Yu S; Wang G; Ma Z; Fu X; Cao Y; Li Q; Xu Z
J Cell Mol Med; 2021 Mar; 25(6):2994-3005. PubMed ID: 33523588
[TBL] [Abstract][Full Text] [Related]
3. Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.
Cao Y; Wei M; Li B; Liu Y; Lu Y; Tang Z; Lu T; Yin Y; Qin Z; Xu Z
Oncotarget; 2016 Apr; 7(17):24242-51. PubMed ID: 27003362
[TBL] [Abstract][Full Text] [Related]
4. Role of EIF4G1 network in non-small cell lung cancers (NSCLC) cell survival and disease progression.
Del Valle L; Dai L; Lin HY; Lin Z; Chen J; Post SR; Qin Z
J Cell Mol Med; 2021 Mar; 25(6):2795-2805. PubMed ID: 33539648
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Tu L; Liu Z; He X; He Y; Yang H; Jiang Q; Xie S; Xiao G; Li X; Yao K; Fang W
Mol Cancer; 2010 Apr; 9():78. PubMed ID: 20398343
[TBL] [Abstract][Full Text] [Related]
6. Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia.
Glück AA; Orlando E; Leiser D; Poliaková M; Nisa L; Quintin A; Gavini J; Stroka DM; Berezowska S; Bubendorf L; Blaukat A; Aebersold DM; Medová M; Zimmer Y
Oncogene; 2018 Jul; 37(30):4181-4196. PubMed ID: 29717265
[TBL] [Abstract][Full Text] [Related]
7. SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.
Xu J; Yang S; Gu X; Shen H; Wang L; Xu W; Fang L; Mao Y; Xu L; Chen Y; Fan W; Wang J
Exp Mol Pathol; 2019 Oct; 110():104276. PubMed ID: 31233732
[TBL] [Abstract][Full Text] [Related]
8. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
10. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
Bilguun EO; Kaira K; Kawabata-Iwakawa R; Rokudai S; Shimizu K; Yokobori T; Oyama T; Shirabe K; Nishiyama M
BMC Cancer; 2020 Sep; 20(1):935. PubMed ID: 32993587
[TBL] [Abstract][Full Text] [Related]
11. CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma.
Mochizuki M; Nakamura M; Sibuya R; Okazaki T; Abe J; Nakagawa T; Takahashi S; Yamazaki T; Imai T; Takano A; Ito H; Yokose T; Miyagi Y; Daigo Y; Sato I; Satoh K; Sugamura K; Yamaguchi K; Tamai K
Lab Invest; 2019 Sep; 99(9):1349-1362. PubMed ID: 31019292
[TBL] [Abstract][Full Text] [Related]
12. CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-eIF4G1 translational regulation axis.
Zhao Y; Li C; Zhang Y; Li Z
Cell Death Dis; 2022 Mar; 13(3):250. PubMed ID: 35301291
[TBL] [Abstract][Full Text] [Related]
13. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
15. IncRNA PLAC2 Upregulates CDK6 by Directly Targeting miR-29C to Promote Cell Proliferation in Lung Squamous Cell Carcinoma.
Zhao X; He X; Wang M; Zhang H; Cheng J; Wang H
Crit Rev Eukaryot Gene Expr; 2022; 32(8):55-67. PubMed ID: 36017916
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis.
Jaiswal PK; Koul S; Shanmugam PST; Koul HK
Sci Rep; 2018 May; 8(1):7459. PubMed ID: 29748619
[TBL] [Abstract][Full Text] [Related]
17. HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Sun Y; Xu D; Zhang C; Wang Y; Zhang L; Qiao D; Bu Y; Zhang Y
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33477943
[TBL] [Abstract][Full Text] [Related]
18. Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma.
Song Y; Sun B; Hao L; Hu J; Du S; Zhou X; Zhang L; Liu L; Gong L; Chi X; Liu Q; Shao S
Oncotarget; 2016 Sep; 7(36):58470-58482. PubMed ID: 27542262
[TBL] [Abstract][Full Text] [Related]
19. TM4SF19-AS1 facilitates the proliferation of lung squamous cell carcinoma by recruiting WDR5 to mediate TM4SF19.
Luo M; Xie L; Su Y; Zhang K; Liang R; Ma Z; Li Y
Mol Cell Probes; 2022 Oct; 65():101849. PubMed ID: 35987447
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
Yuan H; Jiang H; Wang Y; Dong Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
